Make a Difference with a Donation

Research

Landmark Discovery Reveals Cause of Eosinophilic Esophagitis

View a message below from Dr Marc Rothenberg of Cincinnati Children’s Hospital

Click Any of the Links Below to Read Details on Each Clinical Trial

2014 – Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis

2012 – Meritage commences OBS Phase 2 clinical trial for eosinophilic esophagitis

2012 – Cincinnati – Researchers Identify New Regulator in Allergic Diseases

2012 – Cincinnati – Genetic Marker for EE Identified

2011 Research Letter – Feinberg School of Medicine

2010 Donation Letters

Research Letter From Dr. Rothenberg 9-24-09

Eosinophilic Esophagitis (EE) Twins Needed!
Contact Alexandria Greenler, BS via email at alexandria.greenler@cchmc.org

Intravenous QAX576 Treatment for Eosinophilic Esophagitis

A New Discovery CURED Helped Fund – One Step Closer to a CURE

A Study of Flovent in Patients With Eosinophilic Esophagitis

Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis

Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation

Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis

Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years

Trial of Montelukast in Eosinophilic Esophagitis

Topical Steroid Treatment for Eosinophilic Esophagitis

The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis

Data Bank for Eosinophilic Disorders

Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis

Omalizumab to Treat Eosinophilic Gastroenteritis

EGID Parental Stress Study

Intravenous QAX576 Treatment for Eosinophilic Esophagitis

To read more about Clinical Trials, Click Here